FDA's rejection of Moderna threatens to stifle broader vaccine industry
3 months ago
- #FDA
- #public health
- #vaccine industry
- FDA's refusal to review Moderna’s flu vaccine raises concerns about Trump administration policies affecting the vaccine industry.
- Gary Nabel criticizes the decision as unprecedented and harmful to vaccine development and public health.
- Vaccine developers face policy changes under Robert F. Kennedy Jr., including removal of shots from the childhood schedule and canceled mRNA research grants.